Neutral
MediWound Ltd. (NASDAQ:MDWD) Q1 2026 Earnings Call Transcript
MediWound Ltd. reported its Q1 2026 earnings, discussing advancements in its EscharEx and NexoBrid programs. The company highlighted challenges and ad...
Neutral
MediWound Ltd. reported its Q1 2026 earnings, discussing advancements in its EscharEx and NexoBrid programs. The company highlighted challenges and ad...
Neutral
MediWound Ltd. (MDWD) reported a first-quarter loss of $3 million, or 23 cents per share, surpassing Wall Street expectations of a 65-cent loss. Howev...
MediWound Ltd. reported a significant drop in Q1 2026 revenue to $1.5 million from $4.0 million in Q1 2025, primarily due to increased investment in i...
MediWound (NASDAQ: MDWD) has announced its first-quarter 2026 financial results, reporting revenue of $1.5 million and reaffirming full-year 2026 reve...